Ingredient guides

EpiCor Dried Yeast Fermentate

Share

Email article

Published

EpiCor is a dried fermentate of baker's yeast, Saccharomyces cerevisiae. The powder holds the yeast together with the broth it grew in. Its trial reports also call it a dried yeast fermentate. Recent trial reports call it a postbiotic. Its trials in adults used 500 mg a day or a single 500 mg dose.

Terms and sources
dried fermentate
The yeast is grown, then the yeast and its broth are dried together. Moyad et al., Journal of Alternative and Complementary Medicine, 2010; Jensen et al., Frontiers in Nutrition, 2026.
the broth it grew in
With the nutrients and metabolites left in the broth. Moyad et al., Journal of Alternative and Complementary Medicine, 2010.
dried yeast fermentate
Pinheiro et al., BMC Complementary and Alternative Medicine, 2017; Singh et al., Pediatric Research, 2024.
a postbiotic
Jensen et al., Frontiers in Nutrition, 2026; Singh et al., Pediatric Research, 2024. A 2017 report calls it neither a probiotic nor a prebiotic fiber (Pinheiro et al., 2017).
500 mg a day
By a 2017 report, all published human studies to that date used 500 mg a day for adults. Pinheiro et al., 2017.

EpiCor in the body

EpiCor is not a nutrient, and the body has no daily requirement for it. Trial reports say it holds polyphenols, beta-glucan, trace minerals, amino acids and peptides.

Terms and sources
polyphenols
Pinheiro et al., BMC Complementary and Alternative Medicine, 2017. Embria Health Sciences, named there as the maker, commissioned that study. A 2024 report also lists vitamins (Singh et al., 2024).

Its trials measured blood immune cells and cytokines, saliva antibodies, stool habits and diaries of illness symptoms.

Terms and sources
cytokines
Signal proteins of the immune system.

NCCIH describes probiotics as live microorganisms and names the yeast Saccharomyces boulardii among them. NIH ODS quotes a definition from ISAPP that also calls them live. We found no text on EpiCor or on yeast fermentates in the NIH ODS and NCCIH pages on probiotics. Their safety sections are about probiotics as defined above, and do not mention yeast fermentates.

Terms and sources
live microorganisms
NCCIH, Probiotics: Usefulness and Safety.
ISAPP
International Scientific Association for Probiotics and Prebiotics. NIH ODS, probiotics fact sheet for health professionals.
NIH ODS and NCCIH pages
NIH ODS, probiotics fact sheet for health professionals; NCCIH, Probiotics: Usefulness and Safety.

Where EpiCor comes from

EpiCor is made from baker's yeast grown without oxygen and under nutritional stress. The yeast and the nutrients and metabolites of its broth are then dried together into a powder. A 2010 trial report states that a farm-animal feed additive had used the same technology for 60 years.

Terms and sources
baker's yeast
Saccharomyces cerevisiae, baker's yeast variety. Jensen et al., Frontiers in Nutrition, 2026.
without oxygen
Anaerobic. Moyad et al., Journal of Alternative and Complementary Medicine, 2010.
farm-animal feed additive
Moyad et al., Journal of Alternative and Complementary Medicine, 2010. The report calls EpiCor the version modified for people.

Trial reports from 2010 and 2017 name Embria Health Sciences of Ankeny, Iowa, as its developer and maker. The 2026 trial report names Cargill as the manufacturer of EpiCor; Cargill paid for the 2024 and 2026 trials.

Terms and sources
developer and maker
Developed by Embria: Moyad et al., Journal of Alternative and Complementary Medicine, 2010. Produced by Embria: Pinheiro et al., BMC Complementary and Alternative Medicine, 2017.
Cargill
Cargill, Inc., Minnesota, by the funding sections. Jensen et al., Frontiers in Nutrition, 2026; Singh et al., Pediatric Research, 2024.

Daily amounts and the upper limit

The adult trials of EpiCor used 500 mg a day, or one 500 mg dose.

Terms and sources
500 mg a day
For 12 weeks in Moyad et al., 2008, 2009 and 2010, and for 6 weeks in Pinheiro et al., 2017. A single dose in Jensen et al., 2011, listed below, and in Jensen et al., 2026.

United States

There is no US recommended daily amount for EpiCor. The National Academies have not set an upper limit for EpiCor. US labels list EpiCor in mg per serving, without a percent Daily Value.

Terms and sources
percent Daily Value
FDA has not set a Daily Value for it. 21 CFR 101.36.

FDA had no questions about a GRAS notice for dried Saccharomyces cerevisiae yeast fermentate in foods.

Terms and sources
a GRAS notice
GRN 928 from Cargill, Inc. The FDA entry lists drinks, dairy foods, breads, bars, cereals, candy and soups, and names no brand. GRAS is FDA's term "generally recognized as safe" for food ingredients.

124 US labels in the NIH label database name EpiCor. Of the 116 that give its own amount, 72 list 500 mg per serving. 14 labels list EpiCor as the only ingredient, all at 500 mg per serving. The other 110 list it with other ingredients, most often vitamin C, zinc or vitamin D. 38 more labels list a yeast fermentate without the EpiCor name.

Terms and sources
124 US labels
NIH Dietary Supplement Label Database, 214,768 labels, including products no longer sold. Whole-word search for EpiCor in every ingredient and form entry. We counted these.
116 that give its own amount
Amounts range from 50 to 630 mg. The other 8 labels list EpiCor inside a blend, without its own amount. A serving is not always a full day's amount.
the only ingredient
Nutrition Facts lines such as Calories are not counted as ingredients. We counted these.
most often
Vitamin C on 69 of the 124 labels; zinc and vitamin D on 57 each. We counted these.
38 more labels
Names such as Dried Yeast Fermentate or Saccharomyces cerevisiae fermentate; 2 labels call it RenewX. We counted these.

Forms of EpiCor and how they differ

Trials of EpiCor used capsules for adults and gummies for children. The trials here did not test other yeast fermentates. We do not rank forms.

Terms and sources
gummies for children
Two gummies a day with 250 mg each, made by Viva 5. Singh et al., Pediatric Research, 2024. Capsules: Moyad et al., 2010; Jensen et al., 2026.
EpiCor, EpiCor gummies, unbranded dried yeast fermentate, yeast beta-glucan and Saccharomyces boulardii
FormAmount of EpiCorStudies below
EpiCor500 mg a day or one 500 mg dose in adult trialsOne dose: Jensen 2011.
EpiCor gummies250 mg per gummy, two a day, in a trial in childrenNot in the studies below.
Dried yeast fermentate without a brand nameNot stated in our sourcesNot in the studies below.
Yeast beta-glucan, such as WellmuneNo EpiCorA separate ingredient. Not in the studies below.
Live yeast Saccharomyces boulardiiNo EpiCorA separate ingredient. Not in the studies below.

EpiCor dose: Jensen 2011, Jensen 2026 and Pinheiro 2017. Gummies: Singh 2024. Beta-glucan: Stier 2014, a review funded by Leiber, maker of Yestimun. Saccharomyces boulardii: NCCIH.

Published studies of EpiCor

We found no text from NIH ODS or NCCIH that rates the evidence for EpiCor. Of 7 trial reports of EpiCor taken by mouth in PubMed, 6 list an author from Embria or Cargill.

Terms and sources
Embria or Cargill
Embria Health Sciences or Cargill, Inc., by the author lists and disclosure sections. Six reports state that one of the two companies paid. We could not read the seventh report.

Trials whose main measure was illness symptoms are not listed here. Neither are trials in children, trials that chose people by symptoms or a diagnosis, or trials without a random order.

1 study in healthy adults: it found a difference.

The listed trial gave one 500 mg dose and measured blood markers for 2 hours, not symptoms or health outcomes. Embria Health Sciences, named in the report with EpiCor, supplied the product and sponsored the study. Not listed: a single-dose trial whose order of capsules alternated by sex rather than by chance. Also not listed: 2 trials whose main measure was illness symptoms, in adults with and without a recent vaccine. Also not listed: a trial in adults chosen by a diagnosis, and a trial in adults chosen by bowel symptoms. Also not listed: a trial in children, and a test of EpiCor applied to the skin. Lab and animal studies are not listed either.

Our one-line summary comes first. The original is on PubMed.

Show the study
  • Healthy adults took one EpiCor capsule; some immune-cell measures and a blood antioxidant test differed from a dummy capsule.

    Trial · 12 people · One dose, each product · maker-funded

    Jensen et al., Journal of Medicinal Food, 2011

    Terms and sources
    Healthy adults
    12 healthy adults aged 18–54, 9 women and 3 men. People with a known chronic illness were not included.
    one EpiCor capsule
    500 mg with water. Each person took EpiCor and the dummy capsule on two days at least 2 weeks apart. The report calls the order random and does not describe how it was set.
    some immune-cell measures
    CD69 on natural killer cells was higher at 1 hour, and CD25 at 2 hours; both statistically significant. T cells in blood were fewer at 2 hours; statistically significant. Natural killer cells were fewer at 2 hours only after 2 people were left out for not following the protocol. White cells, red cells and granulocytes did not differ.
    a blood antioxidant test
    Serum from each person was tested for antioxidant protection of red blood cells in the lab. It was higher 2 hours after EpiCor; the difference was statistically significant.
    differed
    Compared with the dummy capsule, relative to each person's level before the dose. Five of 6 cytokines did not differ. Interferon-gamma was higher only after the authors removed 2 people's data as outliers. The text places this at 1 hour, the table at 2 hours. The Methods give the significance threshold as P < 0.5; the Results call P < 0.05 significant. The Methods describe no adjustment for multiple comparisons.
    a dummy capsule
    Rice flour in an identical blue capsule.
    maker-funded
    Embria Health Sciences, named with EpiCor in the report, supplied the product and sponsored the study. Two of 7 authors work at Embria.

    Study · Free full text · about 21 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    Twelve healthy adults took one 500 mg EpiCor capsule and, on another day, a dummy capsule, in random order. Blood was drawn before and 1 and 2 hours after. Compared with the dummy capsule, two activation markers on natural killer cells were higher. T cells in blood were fewer at 2 hours. A blood antioxidant test was higher at 2 hours. Five of 6 cytokines did not differ; interferon-gamma differed only after 2 people's data were removed. The trial measured blood markers, not symptoms or health outcomes. Embria Health Sciences supplied EpiCor and sponsored the study.

Sources

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.